Literature DB >> 7624492

Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.

L G Neyens1, W C Alpherts, A P Aldenkamp.   

Abstract

1. A new pyrrolidine derivative (levetiracetam), resembling piracetam, was given as antiepileptic concomitant drug to patients with chronic epilepsy. 2. In a single-blind add-on rising-dose study the cognitive side-effects were investigated twice after one week of administration. 3. The results did not show any significant changes in cognitive performances.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7624492     DOI： 10.1016/0278-5846(95)00022-n

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN： 0278-5846            Impact factor:   5.067


  16 in total

Review 1.  New antiepileptic drugs: comparative studies of efficacy and cognition.

Authors:  Steven L Weinstein; Joan Conry
Journal:  Curr Neurol Neurosci Rep       Date:  2002-03       Impact factor: 5.081

2.  The cognitive impact of antiepileptic drugs.

Authors:  Clare M Eddy; Hugh E Rickards; Andrea E Cavanna
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

Review 3.  Neuropsychological and behavioral effects of antiepilepsy drugs.

Authors:  David W Loring; Susan Marino; Kimford J Meador
Journal:  Neuropsychol Rev       Date:  2007-10-18       Impact factor: 7.444

Review 4.  The efficacy and safety of newer anticonvulsants in patients with dementia.

Authors:  Christian R Dolder; Kimberly L Nealy
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

Review 5.  Treating epilepsy in the elderly: safety considerations.

Authors:  S Arroyo; G Kramer
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

6.  Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database.

Authors:  Francois Chavant; Sylvie Favrelière; Claire Lafay-Chebassier; Caroline Plazanet; Marie-Christine Pérault-Pochat
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

Review 7.  Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors.

Authors:  Marco Mula; Michael R Trimble
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

8.  Increased EEG current-source density in the high Beta frequency band induced by levetiracetam adjunctive therapy in refractory partial epilepsy.

Authors:  Sung-Pa Park; Oh-Young Kwon
Journal:  J Clin Neurol       Date:  2009-12-31       Impact factor: 3.077

9.  Levetiracetam.

Authors:  M Haria; J A Balfour
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

Review 10.  Seizures in elderly patients with dementia: epidemiology and management.

Authors:  Mario Mendez; Gerald Lim
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.